Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-02-23 | Chetan S. Shah, MD Director 47 ... Dr. Shah became a director of Aethlon Medical, Inc. in June 2013. ... Director Compensation for 2015 Fiscal Year ... Chetan S. Shah, MD (6) $39,000 Fees Earned or Paid in Cash, $30,211 Option Awards, Total $69,211. |
| 2017-02-13 | Our Board of Directors presently has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee, on each of which Messrs. Barry and Broenniman and Dr. Shah serve. Mr. Barry is Chairman of the Audit Committee, Mr. Broenniman is Chairman of the Nominating and Corporate Governance Committee, and Dr. Shah is Chairman of the Compensation Committee. ... The following director compensation disclosure reflects all compensation awarded to, earned by or paid to the directors below for the fiscal year ended March 31, 2016. ... Chetan S. Shah, MD (6) $39,000 ... Dr. Shah received stock option grants of 3,684 on June 6, 2014 and 7,520 shares on July 24, 2012 for his service as an outside director. The June 2014 option vested 3,684 shares on March 31, 2015, and the 2014 option vested all 7,520 shares at grant. In January 2015, we paid $14,500 to Dr. Shah in payment of accrued director fees. In October 2015 we paid $39,000 to Dr. Shah in payment of accrued Board of Directors fees for the fiscal year ended March 31, 2015 and in April 2016 we paid $39,000 to Dr. Shah in payment of accrued Board of Directors fees for the fiscal year ended March 31, 2016. |
| 2018-02-16 | Chetan S. Shah, MD Director 49; Board committees: Dr. Shah serves as independent director on Audit and Compensation Committees; Director Compensation for 2017 Fiscal Year: Fees Earned or Paid in Cash $39,000, Stock Awards $94,438, Total $133,438. |
| 2019-02-22 | Dr. Shah became a Director of Aethlon Medical, Inc. in June 2013. ... In the fiscal year ended March 31, 2018, Dr. Shah earned $41,000 related to his role as a Director, a member of our Audit Committee, and as the chair of our Compensation Committee. |
Data sourced from SEC filings. Last updated: 2026-02-03